http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2558863-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4dd0f272517f9280d7a6be9b62a3b430 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2014-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c31986f0e1c967b59108759a825cb3f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b5788d0680cee96af6750f7aee14b54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c9f24cc903415770497bbdc2f01422f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3910c254e9d806c568df2da7059dc7da http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d96193acf980a241dc4aab2e9a8772e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65f96bc0bfa00f6a9087735f9912b8cc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41ba193b52edc2b6588f465b2daa526d |
| publicationDate | 2015-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2558863-C1 |
| titleOfInvention | Method for prediction of haematogenous metastasis in triple negative invasive non-specific breast carcinoma |
| abstract | FIELD: medicine. n SUBSTANCE: method for prediction is implemented as follows: molecular-genetic type of breast cancer is determined by means of immune histochemical test of primary tumour tissue specimens taking into account the primary tumour size; the presence of lymphogenous metastases is detected; a structure of the primary tumour is morphologically studied by counting the number of different structure types in the infiltrative component of the tumour, and an intensity of tumour stroma hyalinosis is assessed. A probability of the haematogenous metastases is determined by formula. If P ≥ 50%, the high risk of the haematogenous metastases is stated. The value P < 50% shows the low risk. n EFFECT: method enables predicting the probability of the haematogenous metastases at higher accuracy and information value in triple negative invasive non-specific breast carcinoma and optimising the therapeutic approach to these patients. n 2 tbl, 2 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2627649-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2623150-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2755242-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2678202-C1 |
| priorityDate | 2014-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.